What is Trulicity and How Does It Work?
Trulicity, known generically as dulaglutide, is a prescription biologic medication designed to help manage blood sugar levels in adults with type 2 diabetes. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. In addition to glycemic control, Trulicity is prescribed to reduce the risk of major adverse cardiovascular events, such as heart attacks or strokes, in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors.
The medication works by mimicking the natural GLP-1 hormone. It stimulates the pancreas to release insulin when blood sugar levels are high, slows gastric emptying to prevent post-meal blood sugar spikes, and reduces the liver’s glucose output by blocking glucagon secretion. These combined actions help maintain stable blood glucose levels throughout the week.
Trulicity Dosage and Administration
Trulicity is administered as a subcutaneous injection once weekly, on the same day each week, at any time of day, with or without food. It comes in single-dose, prefilled injection pens, making self-administration straightforward. Common injection sites include the abdomen, thigh, or upper arm, and it is recommended to rotate injection sites with each dose.
The standard starting dose is typically 0.75 mg once weekly. Depending on the patient’s glycemic response and tolerability, a healthcare provider may gradually increase the dosage to 1.5 mg, 3.0 mg, or a maximum of 4.5 mg once weekly. If a dose is missed, it should be administered as soon as possible, provided the next scheduled dose is at least 3 days (72 hours) away.
Potential Side Effects of Trulicity
Like many medications, Trulicity can cause side effects, though not everyone experiences them. The most common side effects are gastrointestinal in nature, including nausea, vomiting, diarrhea, abdominal pain, decreased appetite, constipation, dyspepsia, and fatigue. These mild side effects often subside within a few days or weeks as the body adjusts to the medication.
Although less common, serious side effects can occur. These include acute pancreatitis, severe hypoglycemia (especially when used in combination with insulin or sulfonylureas), acute kidney injury, worsening of diabetic retinopathy, and gallbladder disease such as cholecystitis or gallstones. Immediate medical attention is required if symptoms of these conditions develop.
Important Warnings and Precautions
Trulicity carries a boxed warning regarding the risk of thyroid C-cell tumors. In animal studies, dulaglutide caused thyroid tumors, though it is unknown if it causes them in humans. Consequently, Trulicity is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Other precautions include monitoring for signs of systemic allergic reactions, avoiding use in patients with severe gastrointestinal disease like gastroparesis, and assessing kidney function in patients with renal impairment. It is also crucial to inform healthcare providers about Trulicity use before undergoing surgeries involving anesthesia, as delayed gastric emptying can increase the risk of pulmonary aspiration.
Drug Interactions and Lifestyle Factors
Trulicity can interact with other medications, particularly those that lower blood sugar, such as sulfonylureas and insulin. Combining these treatments may require dosage adjustments to prevent hypoglycemia. Additionally, because Trulicity delays gastric emptying, it may affect the absorption of orally administered medications.
While there are no specific food restrictions, maintaining a balanced diet and regular exercise routine is essential for optimal results. Alcohol consumption should be limited, as it can unpredictably affect blood sugar levels and complicate diabetes management. Patients who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider to evaluate the risks and benefits of continuing Trulicity therapy.
Leave a Reply